Saturday, July 1, 8 a.m. – 6 p.m.
Sunday, July 2, CLOSED
Monday, July 3, 6 a.m.* – 8 p.m.
Tuesday, July 4, CLOSED
If our hours change we will notify you on the library’s homepage and voicemail – 410-706-7995.
*Hours between 6 and 8 a.m. are limited to those with UMMC and UMB ID badges who enter through the Campus Center.
Gary G. Buterbaugh, PhD, retired professor from the Department of Pharmaceutical Sciences (PSC) at the University of Maryland School of Pharmacy, has committed a gift of $58,000 to the School to establish a new fund in honor of the Class of 1999 for which he served as faculty advisor. The newly created Class of 1999 Award will assist fourth-year student pharmacists with travel to national or state conferences and students who are facing a hardship situation that could interfere with their ongoing pharmacy education.
“Gifts from faculty play an essential role in helping the School of Pharmacy continue to lead pharmacy education, scientific discovery, patient care, and community engagement across the state of Maryland and beyond,” says Ken Boyden, JD, EdD, associate dean for the Office of Development and Alumni Affairs at the School. “The new fund established by Dr. Buterbaugh is unique in that it will not only offer students an opportunity to broaden their education outside of the classroom, but also help to alleviate the financial burden students often face as a result of an unexpected hardship. We thank him for his generosity and are tremendously grateful for his continued support.”
Buterbaugh received his doctorate from the University of Iowa School of Medicine, Department of Pharmacology and Toxicology. He joined the School of Pharmacy as an assistant professor of pharmacology and toxicology in 1969. In the 1990s, he played a crucial role in transforming the School’s three-year Bachelor of Science in pharmacy program into the four-year Doctor of Pharmacy (PharmD) program that faculty, staff, and students recognize today. Although Buterbaugh retired as a professor after more than 40 years of service to the School in 2011, he continues to reflect on his time at the School and his interactions with students. Those interactions motivated him to make a gift to the School.
“I have many memories of my years at the School of Pharmacy,” says Buterbaugh, “But, my most memorable interactions are those that I shared with the students. Although the students of every class had an ineffable impact on me, I remember the Class of 1999 with a special fondness, as it was my good fortune to serve as their faculty advisor. The members of that class demonstrated an exceptionally caring attitude and educational tenacity that blended with their individual integrity, which epitomized and served as a tribute to pharmacy practice. It was my privilege to interact closely with that class, and I am pleased to establish the Class of 1999 Award.”
The lectures, exams, and abilities labs in which students participate at the School provide a strong foundation for their future practice in the pharmacy profession. However, Buterbaugh notes that it is also important for students to have opportunities to make friends, interact with students of other disciplines, and socialize with classmates. As part of these “outside the classroom” activities, some students choose to participate in a national or state pharmacy conference or other professional programming. Buterbaugh designated a portion of the Class of 1999 Award to assist with travel expenses for fourth-year student pharmacists to attend a national or state professional pharmacy conference.
“Both the students who attend professional conferences and the School can benefit from this aspect of my gift,” he says. “Not only do professional meetings provide an opportunity for students to expand their professional network with other men and women who share a common goal of practicing and delivering quality health care, but these students can also share the experience and knowledge that they gained from their involvement in these professional meetings with others at the School. A student at a conference can actively promote the School and its good works.”
Over the more than 40 years that he was part of the School of Pharmacy faculty, Buterbaugh also encountered many students who faced an unexpected hardship situation, which threatened to derail their education.
“In my experience, awards are often bestowed on a person as a result of some ‘distinction,’ such as academic excellence,” says Buterbaugh. “However, every student enrolled in the School of Pharmacy has the distinction of being a person with inimitable life experiences. There are times when a student will encounter an unexpected event that might temporarily interfere with his or her ongoing education. That event must be acknowledged, and any financial burden associated with such an experience eased. A portion of the Class of 1999 Award is delegated to such an event.”
Endowed gifts, such as the Class of 1999 Award established by Buterbaugh, benefit the School, its students, and programs in perpetuity.
“When a person is admitted to the School of Pharmacy as a student, he or she becomes part of a family – the SOP family,” says Buterbaugh. “Everyone who is part of that family (e.g., faculty, staff, students, and alumni) is responsible for that individual’s education and edification. I was blessed with the privilege of interacting with SOP students for many years, and those interactions substantiate my conviction that, although the education of every student must be rigorous and demanding, it should also be unique, fun, memorable, and establish lifelong learning.”
He adds, “It is my hope that this fund will contribute to the School’s responsibility of educating future generations of pharmacy practitioners and help students make the most of their educational experience at the University of Maryland School of Pharmacy.”
The University of Maryland School of Nursing (UMSON) has been awarded Accreditation with Distinction as a Provider of Continuing Nursing Education by the American Nurses Credentialing Center’s (ANCC) Accreditation Program. Accreditation with Distinction is the highest recognition that ANCC awards.
ANCC’s Accreditation Program is a voluntary review process intended to strengthen and sustain the quality and integrity of continuing nursing education (CNE). It identifies organizations worldwide that demonstrate excellence in CNE, providing nurses with the knowledge and skills to help improve care and patient outcomes. Accredited organizations use evidenced-based ANCC criteria to plan, implement, and evaluate CNE activities. Applicants for accreditation must pass a systematic, comprehensive peer review and meet specific standards.
“This award recognizes UMSON’s commitment to excellence and innovation in continuing the education of nurses,” said Patricia Franklin, PhD, RN, assistant professor and director, professional education, UMSON. “We adopted a culture of continuous evaluation to ensure that these learning activities are relevant and responsive to the rapidly changing realities of health care.”
The School also received an Exemplary Finding by demonstrating how it measures change in the audience’s knowledge, skills, and/or practice as a result of participating in the educational activity.
“We congratulate Dr. Franklin and her colleagues in professional education on this significant recognition,” said UMSON Dean Jane M. Kirschling, PhD, RN, FAAN. “It underscores the School of Nursing’s commitment to fostering lifelong learning for members of the nursing profession and serves as a reminder of the importance of the application of evidence-based criteria in all aspects of continuing nursing education.”
A subsidiary of the American Nurses Association, ANCC provides individuals and organizations throughout the nursing profession with the resources they need to achieve practice excellence. ANCC’s internationally renowned credentialing programs certify nurses in specialty practice areas; recognize health care organizations for promoting safe, positive work environments; and accredit providers and approvers of CNE.
University of Maryland School of Nursing (UMSON) assistant professors Catherine Haut, DNP ’10, MS ’93, RN, CRNP, PNP, and Roseann Velez, DNP, CRNP, FNP-BC, were recently inducted as 2017 Fellows of the American Association of Nurse Practitioners (FAANP) at its national conference in Philadelphia. UMSON alumna Pamela Bolton, MS ’92, RN, ACNP, CCNS, PCCN, was also inducted.
The association selects fellows based on outstanding contributions to clinical practice, research, education, or policy.
“We are extremely proud of our newly elected fellows and congratulate them on this honor. It is gratifying that they have been selected by their peers for their contributions,” said UMSON Dean Jane M. Kirschling, PhD, RN, FAAN. “It is a testament to their sustained efforts to promote the role of nurse practitioners and advance the delivery of excellent health care.”
Fellows are charged with supporting the vision and mission of AANP. The FAANP program impacts national and global health by engaging recognized nurse practitioner leaders, the fellows, who make outstanding contributions to clinical practice, research, education, or policy to enhance the association’s mission.
“I’m extremely honored to have be chosen as a fellow of the American Academy of Nurse Practitioners. It has been a privilege to work with many national nursing leaders, including those at the University of Maryland School of Nursing, over the years,” Haut said. “I am very excited to be joining this elite group of nurse practitioners and appreciate the mentorship and support I have received through the years from my colleagues.”
Established in 2000, the FAANP program is dedicated to the global advancement of nurse practitioners and the delivery of high-quality health care. The program not only enhances the association’s mission, but also develops nurse practitioner leaders of the future while furthering the field.
“Becoming a fellow is an honor and a privilege that would not have been possible without the support of my mentors,” Velez said. “I’ve been able to influence the nurse practitioner profession through publications, research, education, and policy, which has been integral to my growth as a professional. Membership in FAANP has enabled me to continue this work by mentoring students striving for FAANP membership and collaborating with colleagues to make an impact locally, nationally, and globally.”
At it’s very simplest, OneDrive is our new, secure, and universally accessible storage location for all your work files.
However, OneDrive offers a lot more than just file storage! It’s an integral part of Office 365 and by using OneDrive, it also allows for:
Once your files are in the OneDrive, you can access them from any computer or mobile device that has internet access. If you’re at a meeting across campus, at home, traveling for work – whatever the scenario – if you need to access your files, you can use either the Office 365 portal or the mobile app.
If you need a colleague to review a file, by using the “Share” feature, they can view and update the file in your OneDrive – their changes will automatically appear in the file. No need to email a file back and forth!
You also can be in the same file as your colleague and both make real time updates.
By using OneDrive to store your files, you gain so much flexibility and accessibility. To help you, the Enterprise Training Group provides both training opportunities and resources. Please visit the Office 365 website for information.
The University of Maryland School of Pharmacy welcomed more than 150 researchers from across academia, government, and industry to Pharmacy Hall in May for “Dissolution and Translational Modeling Strategies Enabling Patient-Centric Product Development,” a multiday conference organized by the University of Maryland Center of Excellence in Regulatory Science and Innovation (M-CERSI) in collaboration with the Food and Drug Administration (FDA). To help address regulatory agencies’ need for a patient-centric assessment of drug product quality in today’s global pharmaceutical environment, the conference featured numerous presentations and breakout sessions that aimed to help attendees better understand the use of dissolution and modeling/simulation approaches in drug product approvals and highlight novel approaches for developing new dissolution testing methods.
“Ensuring quality over the course of a drug product’s life cycle can be challenging,” said James Polli, PhD, the Shangraw/Noxell Endowed Chair in Industrial Pharmacy and Pharmaceutics in the Department of Pharmaceutical Sciences (PSC) at the School of Pharmacy and co-principal investigator for M-CERSI. “The organizers of this conference worked tirelessly to put together an event that I am confident will facilitate many fruitful discussions and help advance our collective understanding of the role of dissolution testing in promoting drug product development and assessment. My special thanks to Dr. Sandra Suarez Sharpe for her efforts to organize the FDA’s participation in this workshop, as well as to the regulatory representatives from Europe, Canada, and Japan who attended our event.”
Drug dissolution testing is an analytical test used to detect physical changes in a drug’s active pharmaceutical ingredient as well as in the finished drug product. It is a requirement for all solid oral dosage forms and provides researchers in regulatory agencies and industry with important in vitro (outside of a living organism) drug release information for both quality control and drug development purposes.
Because it is a key enabler of drug product development and often required by regulatory agencies such as the FDA to justify certain process and formulation changes, effective strategies for developing in vitro dissolution testing methods and establishing corresponding acceptance criteria to ensure product quality are needed throughout a product’s life cycle. However, recent advances in formulation and manufacturing technologies, evolving regulatory expectations, and the development of new testing methods have resulted in inconsistencies in dissolution terminology, limitations for the current regulatory framework, and a lack of understanding on how to effectively implement in vitro and in silico (computer-simulated) approaches to advance product understanding.
“Over the past two decades, we have identified a number of issues related to dissolution testing that remain relevant today,” said Lawrence Yu, PhD, deputy office director for the Center for Drug Evaluation and Research (CDER) at the FDA, in his opening remarks. “My hope is that this conference becomes a starting point for discussions about how we can make progress in this field. Whether it is in how we collect our data or leverage new mathematical modeling approaches, there are many opportunities of which we can take advantage.”
The conference kicked-off with a day of presentations and breakout sessions dedicated to helping attendees better understand the role of dissolution testing in drug product development and as a quality control test. Presenters spoke about the challenges and opportunities that currently exist in the development of new in vitro testing methods to guide product development as well as the justification of quality control method conditions and acceptance criteria.
“Product quality is truly the foundation on which safety and efficacy rests,” said Sarah Pope Miksinski, PhD, office director for CDER at the FDA. “Think about the parent who is awake at 3 a.m. looking for a medication for his or her sick child. That parent is not thinking about the quality of that medication at that moment. He or she expects that the medication will work exactly as its intended. That is a really powerful concept, and it is inherent on us as regulators to remember individuals like that parent, and to make the right decisions using the best available evidence as we review and approve new medications for consumer use.”
During the second day, attendees learned more about the need to establish an in vitro-in vivo (inside of a living organism) link for dissolution testing, including novel approaches and in silico tools currently used in the development of dissolution and permeability testing. The conference concluded on the third day with a discussion of the regulatory applications for dissolution testing.
“This conference truly exceeded my expectations,” said Rob Ju, PhD, head of dissolution sciences for AbbVie. “I am thrilled to have been involved in the many meaningful, logical discussions held over the past three days and cannot wait to attend the next workshop. The knowledge that I gained here will certainly have a lasting impact on my work.”
“All of us attended this conference because we care about patients,” added Andreas Abend, PhD, director at Merck. “Patients rely on the quality of the medications that we develop, and it is our responsibility to ensure that those products work every time they are consumed. It is also symbolic that this event was held at the University of Maryland School of Pharmacy. When you enter a university, you are most likely there to teach or to learn. I think that approach can be applied to many of our attendees – we are all here to learn, to teach, and to influence the direction in which science will lead us.”
Support for the conference was provided in part by AbbVie, Merck, and Novartis.
In our constant pursuit to improve the quality of patients’ lives and the efficacy and humanity of our nation’s health care system, we are the nurse researchers who care about the people and communities with whom we live and work.
In installments throughout the summer, we’ll be highlighting a few of the innovative studies that School of Nursing investigators are leading. We’ll roll out a new video and article every few weeks, each focusing on a different nurse researcher (who) and exploring one of five different areas of research (cares).
Through July 2017, save 20 percent off all 3 oz bottles of Obagi, Image, and Elta sunscreen products at the Maryland Medical Spa.
One bottle lasts all season!
Wednesday, July 26. Additional applications will be considered on a bimonthly basis (September and November 2017) pending availability of funds. Please visit our website for additional information and to download a proposal template.
The purpose of the Faculty Award in Support of Interprofessional Education (IPE) is to encourage and build a community of faculty members across the schools of the University of Maryland, Baltimore (UMB) and throughout the University System of Maryland who have interest and expertise in interprofessional education. This includes, potentially, IPE activities nationally and internationally.
Faculty Awards may be used for a variety of endeavors that can include, but are not limited to, travel to other institutions to study IPE; regional and national meetings focused on IPE, including poster and podium presentations; educational products focused on IPE and other faculty development activities that are inclusive of UMB students from 2 or more schools. The funds must be used within a one-year window and any individual is limited to one award per year. Faculty Awards may provide a one-time salary enhancement stipend, if allowed by the UMB School, and appropriate for the proposed activity.
All UMB faculty members are eligible to apply for a Faculty Award of up to $2,000 annually. Other faculty from the University System of Maryland require a partner from the UMB faculty and are eligible for up to a $1,000 award. A two-page proposal, including a budget, should be submitted via email to the Center for Interprofessional Education. Please include a title for the award, along with a description of the proposed activity and its potential to further IPE at UMB. If you plan to use standardized patients through the Clinical Education and Evaluation Laboratory, please contact the Program Manager, Nancy Budd Culpepper. The co-directors of the Center for Interprofessional Education serve as the award committee.
For questions or to submit an application, please contact:
Patricia Danielewicz
Center for Interprofessional Education
University of Maryland, Baltimore
410-706-4224
pdanielewicz@son.umaryland.edu
This facility will close for maintenance starting Thursday, July 6, at 10 p.m. and will reopen Monday, July 10, at 6 a.m.
Beginning Wednesday, July 5, parkers can relocate to the Saratoga Street Garage on Arch Street. During this maintenance period, you will have access 24/7 to the Saratoga Garage.
Vehicles left in the Lexington Garage after 10 p.m. on July 6 will not be accessible until Monday, July 10.
UMB’s computing environment requires a high level of security to ensure the privacy, integrity, and confidentiality of the data that reside in its systems.
During the last 10 years, the UMID and password have developed and served as a common credential to gain access to systems and services at the University. This authentication strategy has greatly improved the computing services user experience. However, with the growth of cyber threats and attacks, and the attempts to convince individuals to reveal their credential, known as phishing, the computing industry recognized the need to develop a technology to address this problem.
An approach was devised to leverage multiple verification methods and to no longer rely only on a single credential. The combined strength of these multiple factors of authentication create a confidence or level of assurance that the person accessing the system is the appropriate individual.
At UMB, we will be transitioning to a MFA approach that allows users to use a mobile device in addition to their UMID and password to achieve a significantly higher level of security and almost entirely negate the risk associated with phishing and similar attacks.
The Center for Information Technology Services (CITS) has been preparing the computing environment for the implementation of this new technology since last year. CITS also has been coordinating with each school and department to plan the implementation of MFA across the campus.
The first phase of this roll-out will cover the systems that contain the University’s most sensitive data and the users that can access those data. As each of these systems are integrated with MFA, the impacted users will be contacted individually with relevant timelines and instructions for how to set up and use MFA in their daily computing operations.
For more information on this project, check out the CITS site.
Attention Saratoga Garage Pay Daily Staff Parkers!
If you would like to continue to receive the staff pay daily parking rate of $7, your UMB OneCard must be linked to PTS by June 30, 2017.
Starting July 1, pay daily staff without a linked UMB OneCard will pay the full visitor rate. No refunds will be issued.
If you haven’t linked your UMB OneCard, meet the PTS team in the Saratoga Building’s first level conference room for assistance.
We’ll be available from 7:30 to 9:30 a.m. and from 3 to 6 p.m. on Tuesday, June 27, and Wednesday, June 28.
If you have questions, please call Parking and Transportation Services at 6-6603 or 6-5518.
Join the Entrepreneurship and Innovation Network (EIN) for lunch and a talk on funding your innovative idea or startup.
The session will include ways to bring money in for exploring an innovative idea or building your business. Speakers will include successful entrepreneurs with experience raising money for their biotechnology ventures. Cosponsored by USGA, BHI, and EAGB. Food will be served.
The KIC Click scanner on the HS/HSL’s first floor is a high-speed, touch-screen scanner that allows you to quickly scan books, chapters, and other documents.
Save them as PDFs to a USB thumb drive or to your cloud storage service (Google Drive, Dropbox, Microsoft OneDrive, and Box). The touch screen is user friendly and offers options to modify PDFs, such as contrast, color, resolution, and the ability to clip a section. Come by and give it a try!
The National Network of Libraries of Medicine (NNLM) is excited to announce a new web resource, NNLM RD3: Resources for Data-Driven Discovery.
NNLM RD3 is a place for librarians, information professionals, library and information science students, and interested individuals to learn about and discuss research data management throughout the data lifecycle for biomedical and scientific research.
NNLM RD3 contains subject primers, professional development events, and information on the major components of research data management: data management, storage, and sharing. The subject primers provide introductory overviews on topic areas within data literacy, physical sciences, life sciences, and engineering.
Professional development opportunities will be continuously updated. The resources compiled on the site will help you learn the basics of data management and the ins and outs of data visualization, as well serve as a guide to regional and national level activities.